NCT07381166

Brief Summary

This study will evaluate the effect of metered-dose inhaler training and reminders on treatment adherence in elderly individuals.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Jan 2026Jul 2026

Study Start

First participant enrolled

January 21, 2026

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

January 24, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 2, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2026

Last Updated

March 9, 2026

Status Verified

March 1, 2026

Enrollment Period

4 months

First QC Date

January 24, 2026

Last Update Submit

March 5, 2026

Conditions

Keywords

elderlyMetered Dose Inhalersreminderadherence to treatment

Outcome Measures

Primary Outcomes (2)

  • Metered Dose Inhaler Skill

    The "Measured Dose Inhaler Skill Chart" involves evaluating the participant's inhaler usage and checking the application steps. Performing all steps correctly will be considered "correct inhaler technique," while performing at least one or more steps incorrectly or not at all will be considered "incorrect inhaler technique." For each step, incorrect application or omission will receive "0 points," and correct application will receive "1 point," resulting in a total score between "0 and 10." Participants who make at least "1 mistake" or score "below 10" will be included in the study. When evaluating scores based on inhaler usage steps, "0-3" points will be considered poor, "4-6" points moderate, and "7-10" points good.

    the initial screening and three months after the initial screening (three months)

  • Medication Adherence Reporting Scale

    The scale consists of 5 items in total. The total test score is determined by summing the scores obtained from the items. Scores obtained from the scale range from 5 to 25. Higher total scores indicate better medication adherence, while lower total scores indicate poor medication adherence.

    the initial screening and three months after the initial screening (three months)

Study Arms (2)

arm description experimental

EXPERIMENTAL

The socio-demographic and descriptive characteristics, as well as questions regarding medication adherence, included in the survey form will be answered through face-to-face interviews. While the participant demonstrates how to apply the inhaler, the researcher will evaluate the participant's inhaler use according to the "Metered Dose Inhaler Skill Chart," which includes the steps for inhaler use. Each participant in the experimental group will receive metered-dose inhaler training using a demonstration method. At the end of the training, participants will be given a "Metered Dose Inhaler Use Reminder Card" and a "Metered Dose Inhaler Application Video." Participants will also receive weekly reminders via telephone. After 3 months, the experimental group will be contacted via video call to demonstrate how they use the inhaler. The researcher will evaluate the participants' medication adherence scores and record them on the survey form. If any steps are incorrectly applied, the metered

Other: Metered Dose Inhaler TrainingOther: Metered Dose Inhaler Reminder CardOther: Metered Dose Inhaler Application Video

arm description control

NO INTERVENTION

The socio-demographic and demographic characteristics, as well as questions regarding medication adherence, included in the survey form will be answered through face-to-face interviews. While the participant demonstrates how to apply the inhaler, the researcher will evaluate the participant's inhaler use according to the "Metered Dose Inhaler Skill Chart," which includes the steps for inhaler use. No inhaler training or reminders will be given. Participants in the control group will be contacted by phone 3 months after the initial follow-up and asked to demonstrate how they use the inhaler. The researcher will evaluate the participants' medication adherence scores and record them on the survey form. After the data collection is complete, inhaler training will be given to the participants using a demonstration method. At the end of the training, reminder cards and a video demonstrating metered-dose inhaler application will be shared with the participants.

Interventions

It is known that incorrect inhaler use is more common, especially in elderly individuals, and that common errors in metered-dose inhaler use include poor hand-mouth coordination, inability to simultaneously spray and inhale, and failure to hold the breath during inhalation. This study evaluates metered-dose inhaler use only in elderly individuals. Furthermore, not only will the inhaler application steps be evaluated, but the experimental group will also receive education and reminder interventions.

arm description experimental

This reminder card contains the inhaler administration steps included in the "Measured Dose Inhaler Medication Use Skill Chart". Participants in the experimental group will be able to access the medication administration steps on the reminder card before administering their inhaler medication. Participants will be asked in the final interview whether they used the reminder cards.

arm description experimental

This video was prepared by the responsible researcher, taking into account the application steps included in the "Metered Dose Inhaler Medication Use Skill Chart". Participants in the experimental group will be able to access the application steps via the inhaler video before administering their inhaler medication.

arm description experimental

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥ 65 years old
  • Having at least basic literacy,
  • Receiving metered-dose inhaler therapy for at least 6 months,
  • Being hospitalized in the pulmonary ward,
  • Presenting to the pulmonary function test unit,
  • Presenting to the pulmonary outpatient clinic,
  • Signing the informed consent form for participation in the study,
  • Having internet access and a mobile device with Android/iOS operating system,
  • Being able to use a telephone,
  • Having no communication barriers,
  • Being able to use the inhaler without needing assistance,
  • Making an error in at least one of the usage steps according to the MDI usage skills chart.

You may not qualify if:

  • Age \<65
  • Illiteracy
  • Receiving metered-dose inhaler therapy for \<6 months
  • Outpatient treatment
  • Being hospitalized in the intensive care unit
  • Being hospitalized in wards other than the pulmonary ward (such as surgery, physical therapy)
  • Visiting outpatient clinics other than the pulmonary clinic (such as surgery, physical therapy)
  • Not signing the informed consent form for participation in the study
  • Not having internet access and a mobile device with Android/iOS operating system
  • Not having telephone skills
  • Having communication barriers
  • Requiring assistance while using the inhaler
  • Not making any errors in the usage steps according to the MDI usage skills chart
  • Wanting to withdraw from the study/withdrawing from participation during the research process
  • Not completing the questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart University

Çanakkale, 17100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Treatment Adherence and Compliance

Condition Hierarchy (Ancestors)

Health BehaviorBehavior

Study Officials

  • Sevda Ateş, Associate Professor

    Çanakkale Onsekiz Mart University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sevda Ates Associate Professor

CONTACT

Sengül Uzen Cura, Associate Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: experimental design with pre-test and post-test control groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 24, 2026

First Posted

February 2, 2026

Study Start

January 21, 2026

Primary Completion (Estimated)

May 23, 2026

Study Completion (Estimated)

July 30, 2026

Last Updated

March 9, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

In the ethics committee approval and institutional permission obtained for the study, I stated that the study would not be shared anywhere other than for publication.

Locations